Skip to Main Content

Paper Details

Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.
JCO Precis Oncol
7
2021
Author NameAffiliation
Erica K BarnellMcDonnell Genome Institute, Washington University School of Medicine
Zachary L SkidmoreMcDonnell Genome Institute, Washington University School of Medicine
Kilannin KrysiakMcDonnell Genome Institute, Washington University School of Medicine
Lukas D WartmanWashington University School of Medicine
Lukas D WartmanSiteman Cancer Center, Washington University School of Medicine
Stephen T OhSiteman Cancer Center, Washington University School of Medicine
Stephen T OhWashington University School of Medicine
Ravi VijWashington University School of Medicine
Ravi VijSiteman Cancer Center, Washington University School of Medicine
Peter WesterveltWashington University School of Medicine
Peter WesterveltSiteman Cancer Center, Washington University School of Medicine
John F DiPersioWashington University School of Medicine
John F DiPersioSiteman Cancer Center, Washington University School of Medicine
David H SpencerWashington University School of Medicine
David H SpencerSiteman Cancer Center, Washington University School of Medicine
Timothy J LeyWashington University School of Medicine
Timothy J LeySiteman Cancer Center, Washington University School of Medicine
Malachi GriffithMcDonnell Genome Institute, Washington University School of Medicine
Malachi GriffithWashington University School of Medicine
Malachi GriffithSiteman Cancer Center, Washington University School of Medicine
Malachi GriffithWashington University School of Medicine
Obi L GriffithMcDonnell Genome Institute, Washington University School of Medicine
Obi L GriffithWashington University School of Medicine
Obi L GriffithSiteman Cancer Center, Washington University School of Medicine
Obi L GriffithWashington University School of Medicine
  • 1 - 25

Datasets